Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(39 sites)
United States
Beverly Hills Cancer Center, Beverly Hills, California City of Hope Cancer Center, Duarte, California Chao Family Comprehensive Cancer Care and Ambulatory Care, Irvine, California Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California University of California Irvine Medical Center, Orange, California